company background image
BAYERI1 logo

Bayer (Peru) BVL:BAYERI1 Stock Report

Last Price


Market Cap







20 Jun, 2024


Company Financials

BAYERI1 Stock Overview

Engages in the pharmaceuticals, consumer health, and crop science businesses in Peru.

BAYERI1 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance4/6
Financial Health6/6

Bayer S.A. (Peru) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bayer (Peru)
Historical stock prices
Current Share PriceS/20.00
52 Week HighS/20.10
52 Week LowS/14.50
11 Month Change0%
3 Month Change-0.50%
1 Year Change41.84%
33 Year Change41.84%
5 Year Change42.86%
Change since IPO315.80%

Recent News & Updates

Recent updates

Shareholder Returns

BAYERI1PE PharmaceuticalsPE Market

Return vs Industry: BAYERI1 exceeded the PE Pharmaceuticals industry which returned -25.2% over the past year.

Return vs Market: BAYERI1 exceeded the PE Market which returned 15.1% over the past year.

Price Volatility

Is BAYERI1's price volatile compared to industry and market?
BAYERI1 volatility
BAYERI1 Average Weekly Movement2.2%
Pharmaceuticals Industry Average Movement4.7%
Market Average Movement4.1%
10% most volatile stocks in PE Market9.6%
10% least volatile stocks in PE Market1.1%

Stable Share Price: BAYERI1 has not had significant price volatility in the past 3 months.

Volatility Over Time: BAYERI1's weekly volatility (2%) has been stable over the past year.

About the Company

1947n/aHeiko Klaus

Bayer S.A. (Peru) engages in the pharmaceuticals, consumer health, and crop science businesses in Peru. It operates through three segments: Crop Science, Pharmaceuticals, and Consumer Health. The company offers chemical crop protection products to control weeds; seeds and traits for corn, cotton, soybeans, oilseed rape/canola, rice, wheat, and other crops; biological and chemical products to protect crop plants against fungal diseases; biological and chemical products to protect crop plants from harmful insects and their larvae; vegetable seeds; digital applications for agriculture; products for consumer lawn and garden use and forestry, golf courses, railway tracks and landscape applications; biological and chemical seed treatment products to protect against fungal diseases and pests.

Bayer S.A. (Peru) Fundamentals Summary

How do Bayer (Peru)'s earnings and revenue compare to its market cap?
BAYERI1 fundamental statistics
Market capS/294.47m
Earnings (TTM)S/11.79m
Revenue (TTM)S/319.14m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BAYERI1 income statement (TTM)
Cost of RevenueS/224.05m
Gross ProfitS/95.09m
Other ExpensesS/83.30m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date


Earnings per share (EPS)0.80
Gross Margin29.79%
Net Profit Margin3.69%
Debt/Equity Ratio0%

How did BAYERI1 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.